3,896 results match your criteria Budd-Chiari Syndrome


Budd-Chiari syndrome in Behcet's disease: A report of two cases.

Exp Ther Med 2019 Mar 24;17(3):1737-1741. Epub 2018 Dec 24.

Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.

Budd-Chiari syndrome (BCS) is a rare but severe venous form of Behcet's disease (BD) that is caused by the obstruction of the venous outflow tract that transports blood from hepatic veins into the inferior vena cava. In countries where BD is prevalent, including the Middle East and Far East, BCS awareness is important. In the present study, two cases of BCS are presented in two male Chinese patients with BD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2018.7130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364229PMC

Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.

J Clin Exp Hepatol 2019 Jan-Feb;9(1):56-61. Epub 2018 Mar 1.

Consultant, Department of Vascular and Interventional Radiology, Tan Tock Seng Hospital, Singapore.

Background: There has been significant improvement in understanding the etiology and management of Budd-Chiari Syndrome (BCS). Patients with chronic or acute-on-chronic BCS need radiological interventions in the form of angioplasty, hepatic vein/inferior vena cava stenting or Transjugular Intrahepatic Portosystemic Shunt (TIPS). Data regarding the long term follow up of patients undergoing TIPS is limited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jceh.2018.02.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363956PMC
March 2018
3 Reads

Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome.

Can J Gastroenterol Hepatol 2019 2;2019:1673197. Epub 2019 Jan 2.

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy.

Aims: Budd-Chiari Syndrome (BCS) is a rare vascular disease of the liver caused by the obstruction of the hepatic venous outflow located from the small hepatic venules up to the entrance of the inferior vena cava (IVC) into the right atrium. Current prognostic indexes are suboptimal for an individual prognostic assessment and subsequent management of patients with BCS. Liver (LSM) and spleen (SSM) stiffness measurements are widely validated prognostic tools in hepatology, but the evidence in patients with BCS is limited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/1673197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334356PMC
January 2019
2 Reads

Effect of Transjugular Intrahepatic Portosystemic Shunt Creation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: A Prospective Study.

J Vasc Interv Radiol 2019 Feb;30(2):170-177

Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Institute of Interventional Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address:

Purpose: To evaluate effect of transjugular intrahepatic portosystemic shunt (TIPS) creation on pulmonary gas exchange in patients with hepatopulmonary syndrome (HPS).

Materials And Methods: All patients with cirrhosis or Budd-Chiari syndrome undergoing elective TIPS creation at a single institution between June 2014 and June 2015 were eligible for inclusion. Twenty-three patients with HPS (age 55. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2018.09.017DOI Listing
February 2019
1 Read

Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study.

World J Clin Cases 2019 Jan;7(2):130-136

Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110016, Liaoning Province, China.

Background: Collagen proportionate area (CPA) is an important index for assessing the severity of liver fibrosis. Budd-Chiari syndrome can frequently progress to liver fibrosis and cirrhosis. CPA might play an important role in the pathological progress of Budd-Chiari syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v7.i2.130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354089PMC
January 2019
1 Read

Nutmeg liver, fever and elevated liver enzymes in a young man.

Gut 2019 Jan 30. Epub 2019 Jan 30.

Department of Gastroenterology and Hepatology, University Medical Center Ljubljana, Ljubljana, Slovenia.

View Article

Download full-text PDF

Source
http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2018-318099
Publisher Site
http://dx.doi.org/10.1136/gutjnl-2018-318099DOI Listing
January 2019
4 Reads

Clinical treatment of diabetic foot ulcer combined with Budd-Chiari syndrome: A case report.

Medicine (Baltimore) 2019 Jan;98(4):e14224

Department of Orthopedic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.

Rationale: Diabetic foot ulcer is a severe complication of diabetes, and most patients with diabetic foot ulcer require amputation. The incidence of Budd-Chiari syndrome is low; it is relatively rare. Diabetic foot ulcer combined with Budd-Chiari syndrome has not been reported so far. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358405PMC
January 2019
4 Reads
5.723 Impact Factor

Cutting the Gordian Knot of Living-donor Liver Transplantation for Budd-Chiari Syndrome.

Ann Surg 2019 Jan 17. Epub 2019 Jan 17.

Transplantation and Visceral Surgery Units, University Hospitals of Geneva and Ente Ospedaliero Cantonale e Università della Svizzera Italiana, Ticino, Switzerland Visceral Surgery and Transplantation Units, University Hospitals of Geneva, Switzerland Transplantation and Visceral Surgery Units, University Hospitals of Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000003212DOI Listing
January 2019
1 Read

Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari.

J Hepatol 2019 Jan 14. Epub 2019 Jan 14.

Department of Radiology. APHP. University Hospitals Paris Nord Val de Seine. Beaujon, Clichy, France; University Paris Diderot, Sorbonne Paris Cité, Paris, United States; INSERM U1149. CRI. Paris, France. Electronic address:

Background & Aim: To evaluate the diagnostic value of washout for the discrimination between benign and malignant lesions in patients with Budd-Chiari syndrome (BCS).

Methods: This IRB-approved retrospective study included all patients admitted to our institution with a diagnosis of BCS and focal lesions on MR imaging (MRI) from 2000 to 2016. MRI images were reviewed by two radiologists blinded to the nature of the lesions. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278193002
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2019.01.009DOI Listing
January 2019
5 Reads

Catheter Aspiration With Recanalization for Budd-Chiari Syndrome With Inferior Vena Cava Thrombosis.

Surg Laparosc Endosc Percutan Tech 2019 Jan 8. Epub 2019 Jan 8.

Department of Interventional Vascular Surgery, Binzhou People's Hospital, Binzhou.

Purpose: To assess the safety and clinical effectiveness of catheter aspiration with recanalization in patients with Budd-Chiari syndrome (BCS) and inferior vena cava (IVC) thrombosis.

Materials And Methods: Between January 2010 and December 2017, 33 patients with BCS and IVC thrombosis were treated by catheter aspiration with IVC recanalization in our center. A 12 F angled-tip guiding catheter was used for the aspiration of thrombi in the IVC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLE.0000000000000624DOI Listing
January 2019
3 Reads

Pancreaticoduodenectomy complicated by Budd-Chiari syndrome: A case report and review of literature.

World J Gastrointest Surg 2018 Dec;10(9):107-110

Department of Visceral Surgery, Toulouse-Rangueil University Hospital, 31059 Toulouse Cedex 9, France.

Background: Pancreaticoduodenectomy (PD)-induced morbidity, consisting mainly of the pancreatic fistula and its hemorrhagic and infectious consequences, is well described in the literature, in terms of its definition, risk factors, preventive measures, and standardized management of complications. However, some life-threatening complications remain atypical and undescribed.

Case Summary: We report here the case of a 69-year-old patient with Budd-Chiari syndrome that occurred after arterial embolization of postpancreatectomy hemorrhage. Read More

View Article

Download full-text PDF

Source
https://www.wjgnet.com/1948-9366/full/v10/i9/107.htm
Publisher Site
http://dx.doi.org/10.4240/wjgs.v10.i9.107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314861PMC
December 2018
5 Reads

Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd-Chiari syndrome on warfarin.

Hepatol Int 2019 Jan 8. Epub 2019 Jan 8.

Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, 400012, India.

Introduction: Anticoagulation is universally recommended in Budd-Chiari syndrome [BCS]. Vitamin K epoxide reductase complex 1 (VKORC1) and CYP2C9 are involved in the metabolism of warfarin. The present study was done to assess whether these mutations are associated with the risk of bleeding in patients with BCS receiving warfarin. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12072-018-9922-6
Publisher Site
http://dx.doi.org/10.1007/s12072-018-9922-6DOI Listing
January 2019
10 Reads

Type II Abernethy Malformation in a Patient with Primary Budd-Chiari Syndrome.

Ann Hepatol 2018 Dec;18(1):246-249

Department of Intervention, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Budd-Chiari syndrome (BCS) is a heterogeneous group of disorders characterized by hepatic venous outflow obstruction. Abernethy malformation is a congenital vascular malformation defined by diversion of portal blood away from the liver. Both conditions are rare vascular diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/01.3001.0012.7933DOI Listing
December 2018
2 Reads

Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model.

Exp Ther Med 2018 Dec 9;16(6):5227-5235. Epub 2018 Oct 9.

Department of Magnetic Resonance Imaging, Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong 250021, P.R. China.

Budd-Chiari syndrome (BCS) is a rare clinical syndrome caused by the obstruction of hepatic venous outflow. In theory, hepatic congestion and hypoxia induce pathological damage and changes in the liver. However, at present, laboratory evidence supporting this theory is lacking. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2018.6835DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257749PMC
December 2018

Diagnostic accuracy of magnetic resonance angiography for Budd-Chiari syndrome: A meta-analysis.

Exp Ther Med 2018 Dec 19;16(6):4873-4878. Epub 2018 Sep 19.

Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China.

In recent years, the role of magnetic resonance angiography (MRA) in the diagnosis of Budd-Chiari Syndrome (BCS) has been the focus of various clinical studies. The purpose of the present study was to perform a meta-analysis of the diagnostic performance of MRA in patients with BCS by using digital subtraction angiography as a reference method. The search strategy for relevant research articles was based on the Cochrane Handbook for Systematic Reviews, and literature databases (including PubMed, Medline and China National Knowledge Infrastructure) and reference lists of retrieved studies published from 2000 to 2016 were searched. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2018.6764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257683PMC
December 2018

Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis.

Clin Res Hepatol Gastroenterol 2018 Dec 7. Epub 2018 Dec 7.

Department of Gastroenterology, Northern Theater Command General Hospital (formerly General Hospital of Shenyang Military Area), Shenyang, Liaoning Province 110840, PR China. Electronic address:

Background And Aims: The global epidemiological data of Budd-Chiari syndrome (BCS) are scant. A systemic review and meta-analysis aimed to estimate the incidence and prevalence of BCS.

Methods: PubMed, EMBASE, and Cochrane Library databases were searched. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2018.10.014DOI Listing
December 2018
7 Reads

Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.

Eur Radiol 2018 Nov 30. Epub 2018 Nov 30.

Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.

Objectives: To evaluate the changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome (BCS) patients with hepatopulmonary syndrome (HPS).

Methods: From June 2014 to June 2015, all patients with BCS who underwent balloon angioplasty or transjugular intrahepatic portosystemic shunt (TIPS) creation at our institution were eligible for inclusion in this study. Arterial blood gas analysis was performed with the patient in an upright position and breathing room air at 2-3 days and 1 and 3 months after the procedure. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00330-018-5840-1
Publisher Site
http://dx.doi.org/10.1007/s00330-018-5840-1DOI Listing
November 2018
17 Reads

Intravenous Lymphatic Cyst in Inferior Vena Cava - A Rare Cause of Budd-Chiari Syndrome.

Ann Vasc Surg 2018 Nov 27. Epub 2018 Nov 27.

Department of Vascular Surgery, Peking University People's Hospital, Peking University Health Science Center, Peking University, Beijing, 100044, China. Electronic address:

A case with an extremely rare intravenous cystic lesion in suprahepatic inferior vena cava was reported, which originated from the lymphatic system and had induced Budd-Chiari syndrome. To the best of our knowledge, this is the first report of a benign cystic lesion originating from the wall of suprahepatic inferior vena cava that results in Budd-Chiari syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.avsg.2018.08.113DOI Listing
November 2018
2 Reads

Vascular Behçet's syndrome: an update.

Intern Emerg Med 2018 Nov 29. Epub 2018 Nov 29.

Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.

Behçet's syndrome (BS) is a complex vasculitis, characterised by peculiar histological, pathogenetic and clinical features. Superficial venous thrombosis (SVT) and deep vein thrombosis (DVT) are the most frequent vascular involvements, affecting altogether 15-40% of BS patients. Atypical thrombosis is also an important clinical feature of BS, involving the vascular districts of the inferior and superior vena cava, suprahepatic veins with Budd-Chiari syndrome, portal vein, cerebral sinuses and right ventricle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11739-018-1991-yDOI Listing
November 2018
11 Reads

Anti-phospholipid Antibody Syndrome Presenting as Huge Ascites: A Case Report.

Mymensingh Med J 2018 Oct;27(4):883-887

Dr Abed Hussain Khan, Assistant Professor, Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Antiphospholipid Syndrome (APS) is characterized by arterial, venous or small vessel thromboses and/or pregnancy morbidity in the presence of persistently elevated titers of antiphospholipid antibodies. Since virtually any organ can be involved, the clinical presentation of APS is very varied. Abdominal manifestations are rare but may be life-threatening, and include Budd-Chiari Syndrome. Read More

View Article

Download full-text PDF

Source
October 2018
4 Reads

[Membranous occlusion of the inferior vena cava a rare cause of Budd-Chiari syndrome].

Rev Med Liege 2018 Nov;73(11):557-561

Service d'hépatologie, CHU de Liège, Belgique.

Rarely encountered in the Western countries, membranous occlusion of the inferior vena cava results from a fibrous thickening of the intima and is commonly located at the orifices of the hepatic veins. To date, two etiopathogenic hypotheses have been formulated: the first, dealing with the embryological aspect, the second, arguing for a thrombotic origin. Nevertheless, several studies are still underway to understand the exact physiopathological mechanism of this obstruction. Read More

View Article

Download full-text PDF

Source
November 2018
2 Reads

Pediatric Budd-Chiari Syndrome: A Case Series.

Indian Pediatr 2018 Oct;55(10):871-873

Department of Pediatric Surgery, Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India.

Objective: To study the diagnostic methods and treatment outcomes in children with Budd- Chiari syndrome.

Methods: Case records of 25 patients with Budd-Chiari syndrome were evaluated retrospectively. These patients were investigated with imaging techniques and underwent balloon angioplasty or surgical management. Read More

View Article

Download full-text PDF

Source
October 2018
20 Reads

Promising Advances in Budd-Chiari Syndrome in Children.

Indian Pediatr 2018 10;55(10):857-858

Department of General and Hepatobiliary Surgery, Mount Sinai Medical Center, Florida, USA.

View Article

Download full-text PDF

Source
October 2018
2 Reads

Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective.

J Transl Int Med 2018 Sep 9;6(3):97-104. Epub 2018 Oct 9.

Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.

Budd-Chiari syndrome (BCS) is a rare but fatal disease caused by the obstruction in hepatic venous outflow tract (usually by thrombosis) and is further classified into two subtypes depending on the level of obstruction. Patients with BCS often have a combination of prothrombotic risk factors. Clinical presentation is diverse. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/jtim-2018-0022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231303PMC
September 2018
7 Reads

Transthoracic cholecystectomy following biliary pancreatitis arising from a thoracic herniated gallbladder.

J Visc Surg 2018 Dec 9;155(6):513-515. Epub 2018 Nov 9.

Department of HPB Surgery and Liver Transplant, Beaujon Hospital, Clichy, Université Paris VII Diderot, Assistance Publique-Hôpitaux de Paris, 100, boulevard du Général Leclerc, 92110 Clichy, Paris, France.

Asymptomatic right diaphragmatic rupture with liver and gallbladder herniation and secondary Budd-Chiari syndrome is a rare complication of abdominal trauma. In this setting, the management of gallbladder stones remains poorly described and may require a thoracic approach. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18787886183012
Publisher Site
http://dx.doi.org/10.1016/j.jviscsurg.2018.08.007DOI Listing
December 2018
9 Reads

Excellent long-term outcomes of endovascular treatment in budd-chiari syndrome with hepatic veins involvement: A STROBE-compliant article.

Medicine (Baltimore) 2018 Oct;97(43):e12944

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University.

This study aimed to evaluate the long-term efficacy and safety of percutaneous transhepatic balloon angioplasty (PTBA) and transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the treatment of Budd-Chiari syndrome (BCS) with hepatic veins involvement. Between June 2008 and August 2016, a total of 60 BCS patients with hepatic vein involvement in our department were enrolled in this study. Thirty-three cases underwent hepatic vein balloon angioplasty in PTBA Group and 27 cases underwent TIPSS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000012944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221688PMC
October 2018
11 Reads

Outcomes of endovascular interventional therapy for primary Budd-Chiari syndrome caused by hepatic venous obstruction.

Exp Ther Med 2018 Nov 7;16(5):4141-4149. Epub 2018 Sep 7.

Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong 250021, P.R. China.

To date, interventional therapy for patients with Budd-Chiari syndrome (BCS) due to hepatic vein obstruction (HVO) has not been standardized in China. In Western countries, BCS primarily occurs due to thrombosis and the majority of patients receive thrombolysis. In China, BCS is mostly caused by the membranous occlusion of the HV or IVC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2018.6708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201046PMC
November 2018
1 Read

Efficiency of Transluminal Angioplasty of Hepatic Venous Outflow Obstruction in Pediatric Liver Transplantation.

Transplant Proc 2018 Nov 12;50(9):2715-2717. Epub 2018 Apr 12.

Department of Diagnostic Radiology and Liver Transplantation Program, Chang Gung Memorial Hospital Kaohsiung Medical Center, Kaohsiung, Taiwan. Electronic address:

Background: Our aim in this study was to evaluate long-term efficiency of hepatic venous balloon angioplasty (BA) and stent placement (SP) for hepatic venous outflow obstruction (HVOO) in pediatric liver transplantation (LT).

Methods: From January 1999 to September 2016, 262 pediatric patients underwent LT at our hospital. Ten were diagnosed with HVOO, which included 8 living donor grafts and 2 split liver grafts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2018.04.022DOI Listing
November 2018
1 Read

Use of Computed Tomography Volumetry to Assess Liver Weight in Patients With Cirrhosis During Evaluation Before Living-Donor Liver Transplant.

Exp Clin Transplant 2018 Nov 6. Epub 2018 Nov 6.

From the Department of Radiology, Baskent University Faculty of Medicine, Ankara, Turkey.

Objectives: Computed tomography liver volumetry has been widely used to detect total and segmental liver volume in living-donor liver transplantation. However, use of this technique to evaluate the cirrhotic liver remains unclear. In this study, we evaluated the accuracy of freehand computed tomography volumetry to assess total liver volume by comparing weights of total hepatectomy specimens in patients with cirrhosis. Read More

View Article

Download full-text PDF

Source
http://ectrx.org/forms/ectrxcontentshow.php?doi_id=10.6002/e
Publisher Site
http://dx.doi.org/10.6002/ect.2018.0008DOI Listing
November 2018
12 Reads

Dilated abdominal veins from Budd-Chiari syndrome and caval obstruction.

Lancet Gastroenterol Hepatol 2018 Nov;3(11):812

Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(18)30302-9DOI Listing
November 2018
6 Reads

Radical surgical treatment of Budd-Chiari syndrome through entire exposure of hepatic inferior vena cava.

J Vasc Surg Venous Lymphat Disord 2019 Jan 16;7(1):74-81. Epub 2018 Oct 16.

Department of Vascular Surgery, Peking University People's Hospital, Beijing, China. Electronic address:

Objective: Therapies for Budd-Chiari syndrome (BCS) can be divided into three main categories: medical, endovascular, and surgical. Surgery is applicable to the disease when other therapeutic options have failed. We introduce a surgical method of recanalization through exposure of the entire hepatic inferior vena cava (IVC) and hepatic vein (HV) outflow tract for BCS and investigate the long-term outcomes. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S2213333X183013
Publisher Site
http://dx.doi.org/10.1016/j.jvsv.2018.02.007DOI Listing
January 2019
10 Reads

Effects of low-dose energy spectrum scanning combined with adaptive statistical iterative reconstruction on the quality of imaging in Budd-Chiari syndrome.

PLoS One 2018 18;13(10):e0204797. Epub 2018 Oct 18.

Department of Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

Objective: To assess the quality and diagnostic accuracy of monochromatic images combined with adaptive statistical iterative reconstruction (ASIR) performed via spectral computed tomography (CT) in patients with Budd-Chiari syndrome (BCS).

Methods: Sixty-two patients with BCS underwent pectral CT with upper abdominal two-phase contrast-enhanced scanning to generate a 60keV monochromatic energy level combined with ASIR (ranging from 0% -100%) during the portal venous phase (PVP) and the hepatic venous phase (HVP). One-way ANOVA was used to compare vessel-to-liver contrast-to-noise ratio (CNR) for the portal vein (PV), hepatic vein (HV), and inferior vena cava (IVC). Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0204797PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193624PMC
October 2018
6 Reads

Spider's web sign: Budd-Chiari syndrome.

J Med Imaging Radiat Oncol 2018 Oct;62 Suppl 1:110

Department of Radiology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.53_12784DOI Listing
October 2018
7 Reads

Investigation of sensory thresholds in Cavalier King Charles Spaniels with and without Chiari-like malformations and syringomyelia.

J Vet Intern Med 2018 Nov 11;32(6):2021-2028. Epub 2018 Oct 11.

Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina.

Background: Cavalier King Charles Spaniels (CKCS) suffer pain associated with Chiari-like malformation and syringomyelia (CMSM). People suffer from a similar condition and describe numerous sensory abnormalities. Sensory changes have not been quantified in affected CKCS. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jvim.15297
Publisher Site
http://dx.doi.org/10.1111/jvim.15297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272044PMC
November 2018
4 Reads

Hepatic Involvement in Systemic Sarcoidosis.

Am J Case Rep 2018 Oct 11;19:1212-1215. Epub 2018 Oct 11.

Department of Endocrinology, Springfield Clinic, Springfield, IL, USA.

BACKGROUND Sarcoidosis is a systemic disease that can affect any organ, including the liver. It is manifested by the presence of non-caseating granulomas within involved organs, most commonly the pulmonary, lymphatic, and hepatic system. Unlike pulmonary or lymphatic involvement, hepatic involvement is usually asymptomatic and it is underdiagnosed. Read More

View Article

Download full-text PDF

Source
https://www.amjcaserep.com/abstract/index/idArt/910600
Publisher Site
http://dx.doi.org/10.12659/AJCR.910600DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196583PMC
October 2018
16 Reads

Budd-Chiari syndrome: a focussed and collaborative approach.

Hepatol Int 2018 Nov 8;12(6):483-486. Epub 2018 Oct 8.

Department of Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12072-018-9900-z
Publisher Site
http://dx.doi.org/10.1007/s12072-018-9900-zDOI Listing
November 2018
4 Reads

Liver transplantation for inferior vena cava leiomyosarcoma: from a Maslow's hammer to the Occam's razor.

BMJ Case Rep 2018 Sep 28;2018. Epub 2018 Sep 28.

Institute of Liver Disease & Transplantation, Gleneagles Global Health City, Chennai, Tamil Nadu, India.

Leiomyosarcoma (LMS) of primary vascular origin is a rare entity with only potentially curative option being complete surgical resection; despite which the prognosis remains dismal. Tumour recurrence is very common, and the benefits of adjuvant therapy are undefined. A 39-year-old woman presented with 6 months' history of abdominal pain, abdominal distension and pedal oedema. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-225827DOI Listing
September 2018
5 Reads

Doppler ultrasound surveillance of TIPS-patency in the era of covered stents - retrospective analysis of a large single-center cohort.

Z Gastroenterol 2018 09 17;56(9):1053-1062. Epub 2018 Sep 17.

Medizinische Klinik I, Klinikum Ludwigsburg, Germany.

Purpose: The purpose of this study was to determine accuracy and necessity of long-term Doppler ultrasound (DU) surveillance of transjugular intrahepatic portosystemic shunt (TIPS) patency after implantation of an ePTFE-covered stent-graft (Viatorr).

Methods: This single-center retrospective study includes 228 consecutive cirrhotic patients with TIPS implantation due to portal hypertensive complications. Standardized DU surveillance was scheduled 3 - 5 days, 3 months, and 6 months after TIPS implantation and every 6 months thereafter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0044-102107DOI Listing
September 2018
3 Reads

Direct Intrahepatic Portosystemic Shunt in Budd-Chiari Syndrome: A Case Report and Review of the Literature.

Case Rep Radiol 2018 23;2018:9261268. Epub 2018 Aug 23.

Department of Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.

Transjugular intrahepatic portosystemic shunt (TIPS) is an alternative interventional procedure used to manage refractory Budd-Chiari syndrome (BCS) when conservative medical therapy has failed. However, TIPS is not always technically successful because of hepatic vein thrombosis and inability to catheterize the hepatic veins. In these situations, direct intrahepatic portosystemic shunt (DIPS) with access to the portal vein from the IVC has been shown to be a viable alternative that may ameliorate portal hypertension in these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/9261268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126074PMC
August 2018
2 Reads

Thromboembolic disease in females and males aged 10 to 39 years in Germany.

Vasa 2018 Oct 11;47(6):483-489. Epub 2018 Sep 11.

1 Department of Angiology, Helios Klinikum Krefeld, Germany.

Background: We analysed differences in hospitalization rates for venous diseases such as pulmonary embolism (PE), deep vein thrombosis (DVT), sinus vein thrombosis (SVT), portal vein thrombosis (PVT), and Budd-Chiari syndrome (BCS) as well as for arterial diseases such as myocardial infarction (MI) and embolic stroke (ES) in females and males aged 10 to 39 years.

Patients And Methods: Detailed lists of hospitalizations with the principal and additional diagnoses for PE (ICD-code I26.0 + I26. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0301-1526/a000729DOI Listing
October 2018
11 Reads

Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.

Clin Immunol 2018 Dec 18;197:54-59. Epub 2018 Aug 18.

APHP, Service de Médecine Interne et Immunologie clinique, Groupe Hospitalier Pitié Salpétrière Paris, France; DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France. Electronic address:

Objective: To describe the outcome and tolerance in patients treated with anti-TNFα in severe and refractory major vessel disease in Behçet's disease (BD).

Methods: A multicenter study evaluating 18 refractory BD patients with major vessel involvement [pulmonary artery (n = 4), aorta (n = 4) or peripheral artery aneurysm (n = 1) and/or pulmonary artery (n = 7), inferior vena cava (n = 5), or intra-cardiac (n = 3) thrombosis or Budd Chiari Syndrome (n = 2)] treated with anti-TNFα agents.

Results: Vascular remission was achieved in 16 (89%) patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2018.08.004DOI Listing
December 2018
6 Reads

A report on three patients with Echinococcus multilocularis: Lessons learned.

Indian J Gastroenterol 2018 Jul 18;37(4):353-358. Epub 2018 Aug 18.

Fortis Escorts Heart Institute, Okhla Road, New Delhi, 110 025, India.

Echinococcus multilocularis (EM) is the most virulent species of the genus Echinococcus. It causes a highly lethal helminthic disease in humans. The disease may present as hepatic mass mimicking a malignant neoplasm. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12664-018-0860-yDOI Listing
July 2018
21 Reads

Clinical Efficacy of Spectral Computed Tomography for Evaluating Liver Function in Patients with Budd-Chiari Syndrome.

Acad Radiol 2018 Aug 9. Epub 2018 Aug 9.

Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, East Jianshe Road, Zhengzhou, Henan Province 450052, China. Electronic address:

Rationale And Objectives: To analyze the clinical relevance of quantitative spectral parameters in evaluating the treatment of patients with Budd-Chiari syndrome (BCS) with different classes of liver function by comparing normalized iodine concentration (NIC) before and after BCS treatment.

Materials And Methods: Angiographic data were obtained from 41 patients with confirmed BCS between December 2015 and March 2017. All patients underwent spectral computed tomography (CT) before and after BCS treatment; the average interval between scans was 2-4 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2018.05.003DOI Listing
August 2018
3 Reads

Surgical Techniques and Long-term Outcomes of Living-donor Liver Transplantation With Inferior Vena Cava Replacement Using Atriocaval Synthetic Interposition Graft for Budd-Chiari Syndrome.

Ann Surg 2018 Aug 3. Epub 2018 Aug 3.

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Objective: We aimed to describe our living-donor liver transplantation (LDLT) surgical technique and its long-term patency for patients with Budd-Chiari syndrome (BCS) and retrohepatic inferior vena cava (IVC) obstruction that extends up to the atrium.

Background: From a technical perspective, LDLT for BCS with an IVC obstruction up to the right atrium is one of the most challenging surgical procedures. Consequently, the optimal surgical technique for patients with BCS has not yet been elucidated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002847DOI Listing
August 2018
6 Reads

Ultrasonography in Liver Vascular Disease.

Ultraschall Med 2018 Aug 2;39(4):382-405. Epub 2018 Aug 2.

Servicio de Radiodiagnóstico, Hospital Clinic, Barcelona, Spain.

Vascular liver diseases include a heterogeneous group of disorders affecting the micro- and the macro-circulation of the liver. Thrombosis and obstruction of the inflow (portal vein) and/or outflow venous system (Budd-Chiari syndrome), spontaneous porto-systemic shunts, diseases affecting the sinusoids, and hepatic vascular malformations are the most important vascular liver diseases. Thrombosis of the portal venous system and of the hepatic venous system occur most commonly and are potentially life-threatening conditions, while congenital and acquired pro-thrombotic diseases are major causal factors, together with local factors triggering thrombotic events. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0647-1658DOI Listing
August 2018
4 Reads

Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.

PLoS One 2018 31;13(7):e0201525. Epub 2018 Jul 31.

Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Purpose: To investigate the efficacy of percutaneous thermal ablation combined with transarterial chemoembolization (TACE) versus TACE monotherapy in treating primary liver cancer with hepatic vein tumor thrombus (HVTT), and to identify potential factors of overall survival after combination therapy.

Materials And Methods: Patients with primary liver cancer and HVTT from 2011 to 2016 at our institute were retrospectively identified. They were divided into two groups (group A and group B). Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201525PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067729PMC
February 2019
14 Reads
3.230 Impact Factor

Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.

Rofo 2018 08 25;190(8):701-711. Epub 2018 Jul 25.

Department of Radiology, Medical School & Hospital, University of Bonn, Germany.

Background: Transjugular intrahepatic portosystemic shunt (TIPS) is a non-selective portosystemic shunt created using endovascular techniques. During recent years technical improvements and new insights into pathophysiology have modified indications for TIPS placement. In this article we therefore want to discuss current knowledge. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0628-7347DOI Listing
August 2018
4 Reads

Long-term Outcomes of Endoluminal Sharp Recanalization of Occluded Inferior Vena Cava in Budd-Chiari Syndrome.

J Laparoendosc Adv Surg Tech A 2018 Jul 23. Epub 2018 Jul 23.

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, China .

Purpose: To report the long-term results of endoluminal sharp recanalization of occluded inferior vena cava (IVC) in patients with the Budd-Chiari syndrome (BCS).

Patients And Methods: Seventy-two consecutive patients with BCS and IVC occlusion underwent endoluminal recanalization of the IVC occlusion during a 6-year period. BCS with occlusive IVC was detected by reviewing patient history and color Doppler ultrasonography. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/lap.2018.0385DOI Listing
July 2018
7 Reads

Surgical Treatment of Pulmonary Complications in Behçet's Syndrome.

Semin Thorac Cardiovasc Surg 2018 Autumn;30(3):369-378. Epub 2018 Jul 19.

Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey.

We described disease characteristics, management and outcome of a group of Behçet's syndrome (BS) patients who underwent pulmonary lobectomy, segmentectomy or various pleura interventions for complications due to pulmonary artery or descending aorta involvement. There were 9 patients with BS (8 M/1 F; mean age: 24.8 ± 7. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semtcvs.2018.07.008DOI Listing
January 2019
9 Reads

Hepatic vein stenting in a 7 week/old infant with Budd-Chiari syndrome using an anterograde approach from the inferior accessory hepatic vein.

Dig Liver Dis 2018 11 18;50(11):1246. Epub 2018 Jun 18.

Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS-ISMETT), Palermo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.06.004DOI Listing
November 2018
1 Read